Importer of Controlled Substances; Notice of Registration; Lipomed, 39338-39339 [2013-15601]
Download as PDF
<![CDATA[
39338
Federal Register / Vol. 78, No. 126 / Monday, July 1, 2013 / Notices
Drug
Schedule
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate, 72 FR 3417
(2007). Regarding Phenylacetone (8501),
a basic class of controlled substance, no
comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a),
and determined that the registration of
Mallinckrodt, LLC., to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Mallinckrodt, LLC., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
The company plans to import the
listed controlled substance for analytical
research and testing.
The import of the above listed basic
class of controlled substance would be
granted only for analytical testing and
clinical trials. This authorization does
not extend to the import of a finished
FDA approved or non-approved dosage
form for commercial distribution in the
United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Alkermes Gainesville, LLC, to import
the basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971.
DEA has investigated Alkermes
Gainesville, LLC, to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–15589 Filed 6–28–13; 8:45 am]
BILLING CODE 4410–09–P
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form, to package for a clinical trial
study. In addition, the company also
plans to import an ointment for the
treatment of wounds, which contains
trace amounts of the controlled
substance normally found in poppy
straw concentrate for packaging and
labeling for clinical trials.
Comments and requests for any
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417(2007).
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Catalent CTS., Inc., to import the basic
classes of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971.
DEA has investigated Catalent CTS.,
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–15588 Filed 6–28–13; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
[FR Doc. 2013–15603 Filed 6–28–13; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Catalent CTS.,
Inc.
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
By Notice dated April 10, 2013, and
published in the Federal Register on
April 19, 2013, 78 FR 23594, Catalent
CTS., Inc., 10245 Hickman Mills Drive,
Kansas City, Missouri 64137, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Importer of Controlled Substances;
Notice of Registration; Lipomed
Drug Enforcement Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Importer of Controlled Substances;
Notice of Registration; Alkermes
Gainesville, LLC
By Notice dated January 16, 2013, and
published in the Federal Register on
January 29, 2013, 78 FR 6132, Alkermes
Gainesville, LLC, 1300 Gould Drive,
Gainesville, Georgia 30504, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Noroxymorphone (9668),
a basic class of controlled substance
listed in schedule II.
VerDate Mar<15>2010
21:38 Jun 28, 2013
Jkt 229001
Drug
Schedule
Marihuana (7360) .........................
Poppy Straw Concentrate (9670)
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
I
II
Drug Enforcement Administration
By Notice dated April 16, 2013, and
published in the Federal Register on
April 23, 2013, 78 FR 23957, Lipomed,
One Broadway, Cambridge,
Massachusetts 02142, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
JWH–250 (6250) ..........................
E:\FR\FM\01JYN1.SGM
01JYN1
Schedule
I
39339
Federal Register / Vol. 78, No. 126 / Monday, July 1, 2013 / Notices
Drug
Schedule
SR–18 also known as RCS–8
(7008).
JWH–019 (7019) ..........................
JWH–081 (7081) ..........................
SR–19 also known as RCS–4
(7104).
JWH–122 (7122) ..........................
AM–2201 (7201) ...........................
JWH–203 (7203) ..........................
2C–T–2 (7385) .............................
JWH–398 (7398) ..........................
2C–D (7508) .................................
2C–E (7509) .................................
2C–H (7517) .................................
2C–I (7518) ..................................
2C–C (7519) .................................
2C–N (7521) .................................
2C–P (7524) .................................
2C–T–4 (7532) .............................
AM–694 (7694) .............................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Drug
Schedule
Methylphenidate (1724) ................
Sufentanil (9740) ..........................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Lipomed, to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Lipomed, to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–15601 Filed 6–28–13; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
The company plans to import the
listed controlled substances for
packaging, labeling, and distributing to
customers which are qualified clinical
sites, conducting FDA-approved clinical
trials.
The import of the above listed basic
classes of controlled substances would
be granted only for analytical testing
and clinical trials. This authorization
does not extend to the import of a
finished FDA approved or nonapproved dosage form for commercial
distribution in the United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Clinical Supplies Management, Inc., to
import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Clinical Supplies Management, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
[FR Doc. 2013–15575 Filed 6–28–13; 8:45 am]
Importer of Controlled Substances;
Notice of Registration; Clinical
Supplies Management, Inc.
BILLING CODE 4410–09–P
By Notice dated August 17, 2012, and
published in the Federal Register on
VerDate Mar<15>2010
21:38 Jun 28, 2013
Jkt 229001
II
II
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
August 20, 2012, 77 FR 50162, Clinical
Supplies Management, Inc., 342 42nd
Street South, Fargo, North Dakota
58103, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances:
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; SA INTL GMBH
C/O., Sigma Aldrich Co., LLC
By Notice dated March 20, 2013, and
published in the Federal Register on
March 28, 2013, 78 FR 19015, SA INTL
GMBH C/O., Sigma Aldrich Co. LLC.,
3500 Dekalb Street, St. Louis, Missouri
63118, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Alpha-ethyltryptamine (7249) .......
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
N-Benzylpiperazine (7493) ...........
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
E:\FR\FM\01JYN1.SGM
01JYN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 78, Number 126 (Monday, July 1, 2013)]
[Notices]
[Pages 39338-39339]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-15601]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Lipomed
By Notice dated April 16, 2013, and published in the Federal
Register on April 23, 2013, 78 FR 23957, Lipomed, One Broadway,
Cambridge, Massachusetts 02142, made application by letter to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
JWH-250 (6250)............................. I
[[Page 39339]]
SR-18 also known as RCS-8 (7008)........... I
JWH-019 (7019)............................. I
JWH-081 (7081)............................. I
SR-19 also known as RCS-4 (7104)........... I
JWH-122 (7122)............................. I
AM-2201 (7201)............................. I
JWH-203 (7203)............................. I
2C-T-2 (7385).............................. I
JWH-398 (7398)............................. I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-4 (7532).............................. I
AM-694 (7694).............................. I
------------------------------------------------------------------------
The company plans to import analytical reference standards for
distribution to its customers for research and analytical purposes.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Lipomed, to import the basic classes of controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Lipomed, to
ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and
958(a), and in accordance with 21 CFR 1301.34, the above named company
is granted registration as an importer of the basic classes of
controlled substances listed.
Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-15601 Filed 6-28-13; 8:45 am]
BILLING CODE 4410-09-P
